Open-label Study of Dupilumab in Patients With Atopic Dermatitis

NCT01949311 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2733

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Dupilumab

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]